Arsena, H., and S. M. Munir. “Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors Versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials”. Bioscientia Medicina : Journal of Biomedicine and Translational Research, Vol. 10, no. 7, June 2026, pp. 2624-36, doi:10.37275/bsm.v10i7.1638.